Bringing K-Aesthetics to Australia: PharmaResearch Showcases REJURAN at Aesthetics 2026

Following REJURAN's TGA approval in 2023, the company hosted scientific sessions and a clinical masterclass for Australian healthcare professionals. GANGNEUNG, South Korea, Aug. 13, 2026 /PRNewswire/ -- PharmaResearch, the biopharmaceutical company behind REJURAN, recently participated in Aesthetics 2026, an international aesthetic medicine symposium held in Sydney, Australia. The company delivered scientific presentations and clinical education programs focused on its flagship polynucleotide (PN)-based skin booster. Dr. Steven Liew. Photo courtesy of PharmaResearch Aesthetics 2026 brings together dermatologists, plastic surgeons and aesthet…